TargetMol

Lercanidipine hydrochloride

Product Code:
 
TAR-T6874
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6874-10mg10mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6874-1mL1 mL * 10 mM (in DMSO)£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6874-25mg25mg£143.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6874-50mg50mg£207.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6874-100mg100mg£284.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6874-200mg200mg£343.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lercanidipine is a calcium channel blocker of the dihydropyridine class.
CAS:
132866-11-6
Formula:
C36H42ClN3O6
Molecular Weight:
648.2
Pathway:
Membrane transporter/Ion channel; Metabolism
Purity:
0.9981
SMILES:
Cl.COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(c1ccccc1)c1ccccc1
Target:
Calcium Channel

References

Shereen M. Tawakkol, et al. Analytical Chemistry Letters. 2014, 4:255-266. Epstein M, et al. Heart Dis. 2001, 3(6):398-407. Gasser R, et al. Journal of Clinical and Basic Cardiology. 1999, 2(2):169-174. Selvaraj N, et al. J Clin Diagn Res. 2015, 9(11):FF01-5. Canavesi M, et al. J Cardiovasc Pharmacol. 2004, 44(4):416-422.